HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,954,887 | +10.3% | 42,829 | -1.9% | 0.00% | +33.3% |
| Q2 2023 | $4,491,048 | -0.9% | 43,666 | +5.1% | 0.00% | 0.0% |
| Q1 2023 | $4,533,020 | -95.3% | 41,534 | -95.1% | 0.00% | -95.8% |
| Q4 2022 | $95,812,773 | +53.4% | 841,940 | -16.6% | 0.07% | +44.0% |
| Q3 2022 | $62,452,000 | -38.0% | 1,009,088 | -20.1% | 0.05% | -32.4% |
| Q2 2022 | $100,679,000 | -18.1% | 1,262,262 | +8.0% | 0.07% | -5.1% |
| Q1 2022 | $122,933,000 | -5.8% | 1,168,455 | -3.6% | 0.08% | 0.0% |
| Q4 2021 | $130,561,000 | -6.9% | 1,211,592 | -5.4% | 0.08% | -15.2% |
| Q3 2021 | $140,303,000 | +11.9% | 1,280,839 | -4.3% | 0.09% | +13.6% |
| Q2 2021 | $125,335,000 | -0.4% | 1,338,474 | -2.1% | 0.08% | -9.0% |
| Q1 2021 | $125,837,000 | +201.2% | 1,367,203 | +139.4% | 0.09% | +187.1% |
| Q4 2020 | $41,780,000 | -0.6% | 571,149 | +5.5% | 0.03% | -11.4% |
| Q3 2020 | $42,037,000 | +17.8% | 541,142 | -15.7% | 0.04% | +12.9% |
| Q2 2020 | $35,679,000 | +85.8% | 641,932 | -1.0% | 0.03% | +47.6% |
| Q1 2020 | $19,198,000 | -30.6% | 648,164 | -15.2% | 0.02% | -8.7% |
| Q4 2019 | $27,674,000 | +28.4% | 764,483 | -3.4% | 0.02% | +21.1% |
| Q3 2019 | $21,553,000 | +11.0% | 791,510 | -2.0% | 0.02% | +11.8% |
| Q2 2019 | $19,423,000 | – | 807,297 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |